Stock Market News
Fusion Antibodies secures funding from business development agency
Antibody engineering services firm Fusion Antibodies announced on Thursday that it is to create jobs after securing receipt of additional grants from Invest NI.
The AIM-traded company said it will create up to 28 jobs and support additional business development over the next 24 months after Invest NI set out the terms by which the company is entitled to grants totalling up to £0.213m.
Grainne McVeigh, Invest NI's Director of Life Sciences, said: "Invest NI has been working alongside the business for many years and we are delighted to be helping Fusion Antibodies to scale up its workforce and target market opportunities with drug development and diagnostics companies across the globe."
Invest NI is Northern Ireland's regional business development agency and provides support to local businesses in the region and is a substantial shareholder and supporter of the company.
Paul Kerr, chief executive of Fusion Antibodies, said: "These grants will help to fund the expansion of our team as we more than double the capacity of our laboratory and office space, with work expected to be completed by the end of the summer, ahead of our original schedule."
As of 1300 BST, Fusion Antibodies' shares were down 0.97% at 156.00p.
The AIM-traded company said it will create up to 28 jobs and support additional business development over the next 24 months after Invest NI set out the terms by which the company is entitled to grants totalling up to £0.213m.
Grainne McVeigh, Invest NI's Director of Life Sciences, said: "Invest NI has been working alongside the business for many years and we are delighted to be helping Fusion Antibodies to scale up its workforce and target market opportunities with drug development and diagnostics companies across the globe."
Invest NI is Northern Ireland's regional business development agency and provides support to local businesses in the region and is a substantial shareholder and supporter of the company.
Paul Kerr, chief executive of Fusion Antibodies, said: "These grants will help to fund the expansion of our team as we more than double the capacity of our laboratory and office space, with work expected to be completed by the end of the summer, ahead of our original schedule."
As of 1300 BST, Fusion Antibodies' shares were down 0.97% at 156.00p.
Related share prices |
---|
Fusion Antibodies (FAB) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price